These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6762719)
1. Antithymocyte globulin in cadaver renal grafts: prophylaxis and antirejection therapy with three different preparations. MacDonald AS; Belitsky P; Lannon SG; Cohen A; White J Transplant Proc; 1982 Dec; 14(4):631-4. PubMed ID: 6762719 [TBL] [Abstract][Full Text] [Related]
2. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin. Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts. Pescovitz MD; Book BK; Milgrom ML; Leapman SB; Petersen B; Filo RS Surgery; 1994 Oct; 116(4):811-8. PubMed ID: 7940183 [TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Cosimi AB; Wortis HH; Delmonico FL; Russell PS Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Wieneke H; Otte B; Lang D; Heidenreich S Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953 [TBL] [Abstract][Full Text] [Related]
6. Improved graft prognosis by treatment of steroid resistant rejections with ATG and plasmapheresis. Fassbinder W; Scheuermann EH; Stutte HJ; Bechstein PB; Fürsch A; Ernst W; Schoeppe W Proc Eur Dial Transplant Assoc; 1983; 20():362-7. PubMed ID: 6361750 [TBL] [Abstract][Full Text] [Related]
7. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era. Hariharan S; Alexander JW; Schroeder TJ; First MR Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516 [TBL] [Abstract][Full Text] [Related]
8. A prospective randomized comparison of antilymphoblast globulin versus antithymocyte globulin for cadaver kidney transplantation. Toledo-Pereyra LH; Bergren C; Mittal VK; Whitten JI; Baskin S; McNichol L Transplantation; 1985 Oct; 40(4):448-50. PubMed ID: 3901446 [No Abstract] [Full Text] [Related]
9. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation. Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564 [TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170 [TBL] [Abstract][Full Text] [Related]
11. Reversal of acute renal allograft rejection with adjunctive AG therapy. Filo RS; Smith EJ; Leapman SB Transplant Proc; 1981 Mar; 13(1 Pt 1):482-90. PubMed ID: 7022879 [TBL] [Abstract][Full Text] [Related]
12. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids. Cantarovich D J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885 [TBL] [Abstract][Full Text] [Related]
13. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital. Delmonico FL Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062 [No Abstract] [Full Text] [Related]
14. Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen. Wechter WJ; Brodie JA; Morrell RM; Rafi M; Schultz JR Transplantation; 1979 Oct; 28(4):294-302. PubMed ID: 388762 [TBL] [Abstract][Full Text] [Related]
15. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation]. Hourmant M; Soulillou JP Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191 [TBL] [Abstract][Full Text] [Related]
16. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience. Malinow L; Walker J; Klassen D; Oldach D; Schweitzer E; Bartlett ST; Weir MR Clin Transplant; 1996 Jun; 10(3):237-42. PubMed ID: 8826659 [TBL] [Abstract][Full Text] [Related]